scholarly journals Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines

2019 ◽  
Vol 7 (4) ◽  
pp. 723-725
Author(s):  
Maiko Yokoyama ◽  
Gyohei Egawa ◽  
Takamitsu Makino ◽  
Kiyofumi Egawa
1959 ◽  
Vol 79 (5) ◽  
pp. 587 ◽  
Author(s):  
WILLIAM B. REED

2017 ◽  
Vol 2 (1) ◽  
pp. 83-85
Author(s):  
Anca Chiriac ◽  
Piotr Brzezinski ◽  
Cristian Podoleanu ◽  
Simona Stolnicu

AbstractBackground:Anogenital premalignancies and malignancies often affect females and males, and human papillomavirus infection plays a crucial role in their etiopathogenesis. These lesions are very important and represent an immense public health burden.Case presentation:A 78-year-old Caucasian male presented to the Dermatology Unit for persistent, slowly progressing, well-demarcated, erythematous plaques on the glans penis, observed by the patient 18 months prior to the consultation. Variable topical treatments were applied, with no improvement and with the denial of a punch biopsy. A clinical diagnosis of erythroplasia of Queyrat was established and the test for HPV revealed an association with subtype 16 (which excluded other benign inflammatory conditions). Positive results were obtained after 4 weeks of topical application of 5% imiquimod cream, once daily, 5 times a week.Conclusion:Erythroplasia of Queyrat should be diagnosed in a non-compliant patient based on the clinical picture and HPV testing even in the absence of a biopsy, and a non-surgical treatment should be initiated immediately.


2005 ◽  
Vol 31 (11) ◽  
pp. 1454-1457 ◽  
Author(s):  
Jesús del Pozo Losada ◽  
Asunción Ferré ◽  
Begoña San Román ◽  
Vanessa Vieira ◽  
Eduardo Fonseca

2018 ◽  
Vol 60 (3) ◽  
Author(s):  
Su‐Lin Chan ◽  
Richard Edward Watchorn ◽  
Evangelia Panagou ◽  
Evdoxia Panou ◽  
Eugene LH Ong ◽  
...  

2018 ◽  
Vol 28 (3) ◽  
pp. 405-406 ◽  
Author(s):  
Qian-Nan Jia ◽  
Giang Huong Nguyen ◽  
Kai Fang ◽  
Hong-Zhong Jin ◽  
Yue-Ping Zeng

Sign in / Sign up

Export Citation Format

Share Document